Skip to content

Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

Unknown statusNot applicableNCT05059418
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The first part of this study is to optimize diagnostic criteria for BMS, i.e. not a clinical trial, and will not be covered in this application. The second part will compare topical treatment with clonazepam, capsaicin and placebo in a n-of-1 study design regarding effects of pain, pain-related disability, somatosensory changes in the trigeminal nerve and patient experience in patients with primary BMS or other oral mucosal pain. The patients will be treated for two weeks with each drug, with a one-week wash-out period in between. After the last washed-out period, the patients will be able to chose the treatment that they prefer the most and continue with that treatment during 6 months.

Study details

Official title
Burning Mouth Syndrome - Optimized Diagnostic Criteria and Treatment
Conditions
  • Burning Mouth Syndrome
Interventions
Sponsor
Malmö University
Collaborators
Lund University
Start date
2021-11-01
Primary completion
2023-12-31
Sex
Female
Age range
from 30 Years to 80 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of primary BMS according to International Classification of Orofacial Pain (ICOP) OR diagnosis of other oral mucosal pains according to ICOP Exclusion Criteria: * Fibromyalgia * IBS * Reflux * Recent (\<3 months) intraoral surgical procedure * Ongoing medication with Clonazepam or Capsaicin

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05059418